deltatrials
Completed NA INTERVENTIONAL 9-arm NCT04258501

Exploratory Study of Efficacy on Selected Natural Extracts Reducing Post Prandial Blood Glucose Response

An Exploratory Study of Efficacy and Tolerance on Selected Natural Extracts, With the Potential of Reducing Post Prandial Blood Glucose Response, in Healthy Indian Adult Subjects

Sponsor: Lambda Therapeutic Research Ltd.

Conditions Blood Glucose
Updated 4 times since 2020 Last updated: Feb 4, 2020 Started: Nov 24, 2011 Primary completion: Jan 6, 2012 Completion: Jan 6, 2012
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Blood Glucose, this trial is completed. The trial is conducted by Lambda Therapeutic Research Ltd. and has accumulated 4 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

4 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Mar 2020 — Jan 2021 [monthly]

    Completed NA

    First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Lambda Therapeutic Research Ltd.
  • Unilever R&D
Data source: Unilever R&D

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations